Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III

Journal of Lipid Research

Volumn 37, Issue 1, 1996, Pages 136-147

  Dallinga Thie, Geesje M ^a   Bu, Xiang Dong ^b   Van Linde Sibenius Trip, Margreet ^a   Rotter, Jerome I ^b   Lusis, Aidons J ^c   De Bruin, Tjerk W A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

linkage; multigenic hypercholesterolemia; sibpair analysis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN; MALE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; APOLIPOPROTEINS C; BASE SEQUENCE; BODY MASS INDEX; CHOLESTEROL, LDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LINKAGE (GENETICS); MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; NETHERLANDS; NUCLEAR FAMILY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIGLYCERIDES;

EID: 0030069735     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Goldstein, J. L., H. G. Schrott, W. R. Hazzard, E. L. Bierman, and A. G. Motulsky. 1973. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52: 1544-1568.
2. Iselius, L. 1981. Complex segregation analysis of hypertriglyceridemia. Hum. Hered. 31: 222-226.
3. Williams, W. R., and J. M. Lalouel. 1982. Complex segregation analysis of hyperlipidemia in a Seattle sample. Hum. Hered. 32: 24-36.
4. Cullen, P., B. Farren, J. Scott, and M. Farrall. 1994. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. Arterioscler. Thromb. 14: 1233-1249.
5. Brunzell, J. D., J. J. Albers, A. Chait, S. M. Grundy, E. Groszek, and G. B. McDonald. 1983. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J. Lipid Res. 24: 147-155.
6. Kwiterovich, P. O. 1993. Genetics and molecular biology of familial combined hyperlipidemia. Curr. Opin. Lipidol. 4: 133-143.
7. Castro Cabezas, M., T. W. A. de Bruin, and D. W. Erkelens. 1992. Familial combined hyperlipidemia: 1973-1991. Neth. J. Med. 40: 83-95.
8. Cortner, J. A., P. M. Coates, M. J. Bennett, D. R. Cryer, and N-A. Le. 1991. Familial combined hyperlipidemia: use of stable isotopes to demonstrate overproduction of very low density apolipoprotein B by the liver. J. Inherited Metab. Dis. 14: 915-922.
9. Venkatesan, S., P. Cullen, P. Pacy, D. Halliday, and J. Scott. 1993. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler. Thromb. 13: 1110-1118.
10. Chait, A., J. J. Albers, and J. D. Brunzell. 1980. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridemia. Eur. J. Clin. Invest. 110: 12-22.
11. Kissebah, A. H., S. Alfarsi, and P. W. Adams. 1981. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 30: 856-868.
12. DeJager, S., E. Bruckert, and M. J. Chapman. 1993. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J. Lipid Res. 34: 295-308.
13. Austin, M. A. 1993. Genetics of low-density lipoprotein subclasses. Curr. Opin. Lipidol. 4: 125-132.
14. Hunt, S. C., L. L. Wu, P. N. Hopkins, B. M. Stults, H. Kuida, M. E. Ramirez, J. M. Lalouel, and R. R. Williams. 1989. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosder. Thromb. 9: 335-344.
15. Austin, M. A., J. D. Brunzell, W. L. Fitch, and R. M. Krauss. 1990. Inheritence of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arterioscler. Thromb. 10: 520-530.
16. Austin, M. A., E. Wijsman, S. Guo, R. M. Krauss, J. D. Brunzell, and S. Deeb. 1991. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia. Genet. Epidemiol. 8: 287-297.
17. Castro Cabezas, M., T. W. A. de Bruin, H. A. de Valk, C. C. Shoulders, H. Jansen, and D. W. Erkelens. 1993. Impaired fatty acid metabolism in familial combined hyperlipidemia. J. Clin. Invest. 92: 160-168.
18. Brunzell, J., T. Mazzone, A. Motulsky, and J. J. Albers. 1982. Abnormalities in high density lipoprotein composition in familial combined hyperlipidemia. Arterioscler. Thromb. 2: 416a-417a.
19. Rauh, G., H. Schuster, B. Muller, S. Schewe, C. Keller, G. Wolfram, and N. Zollner. 1990. Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia. Atherosclerosis. 83: 81-87.
20. Coresh, J., T. H. Beaty, P. O. Kwiterovich, and S. E. Antonarakis. 1992. Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels. Am. J. Hum. Genet. 50: 1038-1045.
21. Wojciechowski, A. P., M. Farrall, P. Cullen, T. M. E. Wilson, J. D. Bayliss, B. A. Griffin, M. D. Caslake, C. J. Packard, J. Shepherd, R. Thakker, and J. Scott. 1991. Familial combined hyperlipidemia linked to the apolipoprotein A-I/C-III/A-IV gene cluster on chromosome 11q23-q24. Nature. 349: 161-164.
22. Wijsman, E. M., A. G. Motulsky, S. W. Guo, M. Yang, M. A. Austin, J. D. Brunzell, and S. Deeb. 1992. Evidence against linkage of familial combined hyperlipidemia to the apoAI-CIII-AIV gene complex. Circulation. 86, suppl. 1: 1420.
23. Ito, Y., N. Azrolan, A. O'Connell, A. Walsh, and J. L. Breslow. 1990. Hypertriglyceridemia as a result of human apoC-III gene expression in transgenic mice. Science. 249: 790-793.
24. de Silva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.
25. Aalto-Setala, K., E. A. Fisher, X. Chen, T. Chajek-Saul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein C-III transgenic mice. J. Clin. Invest. 90: 1889-1900.
26. Castro Cabezas, M., T. W. A. de Bruin, H. Jansen, L. A. W. Kock, W. Kortlandt, and D. W. Erkelens. 1993. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler. Thromb. 13: 804-814.
27. Mehrabian, M., and A. J. Lusis. 1992. Genetic markers for studies of atherosclerosis and related risk factors. In Molecular Genetics of Coronary Heart Disease. Candidate Genes and Processes in Atherosclerosis. A. J. Lusis, J. I. Rotter, and R. S. Sparkes, editors. S. Karger, AG, Basel, Switzerland. 363-418.
28. Bruin, T. W. A. de, C. B. Brouwer, J. A. Gimpel, and D. W. Erkelens. 1991. Postprandial decrease in HDL cholesterol and HDL apoA-I in normal subjects in relation to triglyceride metabolism. Am. J. Physiol 260: 492-498.
29. Friedewald, W. T., R. I. Levy, and D. S. Frederickson. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation. Clin. Chem. 18: 499-502.
30. Marcovina, S. M., J. J. Albers, H. Kennedy, J. V. Mei, L. O. Henderson, and W. H. Hannon. 1994. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. IV. Comparability of apolipoprotein B values by use of international reference material. Clin. Chem. 40: 586-592.
31. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
32. Shoulders, C. C., T. M. E. Narcisi, J. J. Jarmuz, J. D. Bayliss, and J. Scott. 1993. Characterization of genetic markers in the 5′ flanking region of the apoA-I gene. Hum. Genet. 91: 197-198.
33. Karathanasis, S. K., V. I. Zannis, and J. L. Breslow. 1985. Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles. J. Lipid Res. 26: 451-456.
34. Jeenah, M., A. Kessling, N. Miller, and S. Humphries. 1990. G to A substitution in the promotor region of the apolipoprotein A-I gene is associated with elevated serum apolipoprotein A-I and high density lipoprotein cholesterol concentration. Mol. Biol. Med. 7: 233-241.
35. Terwilliger, J. D., and J. Ott. 1994. Handbook of Human Genetic Linkage. John Hopkins University Press, Baltimore.
36. Hasemann, J. K., and R. C. Elston. 1992. The investigation of linkage between a quantitative trait and a marker locus. Behavior Genet. 2: 3-19.
37. Elston, R. C. 1990. S.A.G.E. Statistical Analysis for Genetic Epidemiology.
38. Warden, C. H., A. Daluiski, X. Bu, D. A. Purcell-Huynh, C. de Meester, B-H. Shieh, D. L. Puppione, R. M. Gray, G. M. Reaven, Y-D. I. Chen, J. I. Rotter, and A. J. Lusis. 1993. Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans. Proc. Natl. Acad. Sci. USA. 90: 10886-10890.
39. Amos, C. I., R. C. Elston, S. R. Srinivasan, A. F. Wilson, J. L. Cresanta, L. J. Ward, and G. S. Berenson. 1987. Linkage and segregation analysis of apolipoproteins A-I and B, and lipoprotein cholesterol levels in a large pedigree with excess coronary heart disease: the Bogalusa Heart Study. Genet. Epidemiol. 4: 115-128.
40. Hayden, M. R., H. Kirk, H. Campbell, J. Frohlich, S. Rabkin, R. McLeod, and J. Hewitt. 1987. DNA polymorphism in and around the apoA-I/C-III genes and genetic hyperlipidemia. Am. J. Hum. Genet. 40: 421-430.
41. Lopez-Miranda, J., J. M. Ordovas, A. Espino, C. Marin, J. Salas, F. Lopez-Segura, J. Jimenez-Pereperez, and F. Perez-Jimenez. 1994. Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat. Lancet. 343: 1246-1249.
42. Mata, P., J. M. Ordovas, J. Lopez-Miranda, A. H. Lichtenstein, B. Clevidence, J. T. Judd, and E. J. Schaefer. 1994. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler. Thromb. 14: 884-891.
43. Ordovas, J. M., F. Civeira, J. R. Genest, J. S. Craig, A. H. Robbins, T. Meade, M. Pocovi, P. M. Frossard, U. Masharani, P. W. Wilson, D. N. Salem, R. H. Ward, and E. J. Schaefer. 1991. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis. 87: 75-86.
44. Thompson, E. A., S. Deeb, D. Walker, and A. G. Motulsky. 1988. The detection of linkage disequilibrium between closely linked markers: RFLPs at the A-I/C-III apolipoprotein genes. Am. J. Hum. Genet. 42: 113-124.
45. Talmud, P. J., Y. Shu, and S. E. Humphries. 1991. Polymorphism in the promoter region of the apolipoprotein A-I gene associated with differences in apolipoprotein A-I levels: the European Atherosclerosis Research study. Genet. Epidemiol. 11: 265-280.
46. Kessling, A. M., R. Taylor, A. Temple, J. Hutson, A. Hidalgo, and S. E. Humphries. 1988. A PvuII polymorphism in the 5′ flanking region of the apolipoprotein A-IV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration. Hum. Genet. 78: 237-239.
47. Berg, K. 1989. Predictive genetic testing to control coronary heart disease and hyperlipidemia. Arterioscler. Thromb. 9: 150-158.
48. Rotter, J. I., X. Bu, R. M. Cantor, C. H. Warden, J. Brown, R. J. Gray, P. J. Blanche, R. M. Krauss, and A. J. Lusis. 1994. Multiple genes determine LDL particle size phenotype in coronary artery disease families. Circulation. 88: 509.
49. Marasco, O., F. Melina, E. Mele, B. Quaresime, A. Zingone, E. Focarelli, E. Picciotti, M. L. Martelli, L. Fotino, M. F. Vigna, F. Baudi, A. Dominijanni, E. Angotti, A. Pujia, N. Perrotti, A. Colonna, P. L. Mattioli, A. Porcellini, F. Costanzo, and V. E Avvedimento. 1993. Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein A-I/C-III gene cluster on chromosome 11. Hum. Genet. 91: 169-174.
50. Pagani, F., A. Sidoli, G. A. Giudici, L. Barenghi, C. Vergani, and F. E. Baralle. 1990. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J. Lipid Res. 31: 1371-1377.
51. Saha, N., J. S. H. Tay, P. S. Low, and S. E. Humphries. 1994. Guanidine to adenine (G/A) substitution, in the promoter region of the apolipoprotein A-I gene is associated with elevated serum apolipoprotein A-I levels in Chinese non-smokers. Genet. Epidemiol. 11: 255-264.
52. Angotti, E., E. Mele, F. Costanzo, and E. V. Awedimento. 1994. A polymorphism (G → A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J. Biol. Chem. 269: 17371-17374.
53. Tuteja, R., N. Tuteja, C. Melo, G. Casari, and F. E. Baralle. 1992. Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Lett. 304: 98-101.
54. Smith, J. D., E. A. Brinton, and J. L. Breslow. 1992. Polymorphism in the human apolipoprotein A-I gene promoter region: association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J. Clin. Invest. 89: 1796-1800.
55. Shoulders, C. C., P. J. Harry, L. Lagrost, S. E. White, N. F. Shah, J. D. North, M. Gilligan, P. Gambert, and M. J. Ball. 1991. Variation at the apoA-I/C-III/A-IV gene complex is associated with elevated plasma levels of apoC-III. Atherosclerosis. 87: 239-247.
56. Rees, A., J. Stocks, C. R. Sharpe, M. A. Vella, C. C. Shoulders, J. Katz, N. I. Jowett, F. E. Baralle, and D. J. Galton. 1985. Deoxyribonucleic acid polymorphism in the apolipoprotein A-I/C-III gene cluster. Association with hypertriglyceridemia. J. Clin. Invest. 76: 1090-1095.
57. Dammerman, M., L. A. Sandkuyl, J. J. Halaas, W. Chung, and J. L. Breslow. 1993. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc. Natl. Acad. Sci. USA. 90: 4562-4566.
58. Helio, T., A. Paliotie, T. Sane, M. J. Tikkanen, and K. Kontula. 1994. No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes. Hum. Genet. 94: 271-278.
59. Paul-Hayase, H., M. Rosseneu, D. Robinson, J. P. V. Biervliet, J. P. Deslypere, and S. E. Humphries. 1992. Polymorphisms in the apolipoprotein A-I/C-III/A-IV gene cluster: detection of genetic variation determining plasma apoA-I, apoC-III and apoA-IV concentrations. Hum. Genet. 88: 439-446.
60. Haase, A., and W. Stoffel. 1990. The 3′-flanking region shared by the human apolipoprotein A-I and C-III gene regulates gene expression in cooperation with 5′-flanking elements. Biol. Chem. Hoppe-Seyler. 371: 375-382.
61. Ogami, K., M. Hadzopoulou-Cladaras, C. Cladaras, and V. I. Zannis. 1990. Promotor elements and factors required for hepatic and intestinal transcription of the human apoC-III gene. J. Biol. Chem. 265: 9808-9815.
62. Reue, K., T. Leff, and J. L. Breslow. 1988. Human apolipoprotein C-III gene expression is regulated by positive and negative cis-acting elements and tissue-specific protein factors. J. Biol. Chem. 263: 6857-6864.
63. Wang, C., W. J. McConathy, H. J. Kloer, and P. Alaupovic. 1985. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J. Clin. Invest. 75: 384-390.